114 related articles for article (PubMed ID: 16675848)
1. Reactive microgliosis participates in MPP+-induced dopaminergic neurodegeneration: role of 67 kDa laminin receptor.
Wang T; Zhang W; Pei Z; Block M; Wilson B; Reece JM; Miller DS; Hong JS
FASEB J; 2006 May; 20(7):906-15. PubMed ID: 16675848
[TBL] [Abstract][Full Text] [Related]
2. MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration.
Wang T; Pei Z; Zhang W; Liu B; Langenbach R; Lee C; Wilson B; Reece JM; Miller DS; Hong JS
FASEB J; 2005 Jul; 19(9):1134-6. PubMed ID: 15845609
[TBL] [Abstract][Full Text] [Related]
3. Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.
Hu X; Zhang D; Pang H; Caudle WM; Li Y; Gao H; Liu Y; Qian L; Wilson B; Di Monte DA; Ali SF; Zhang J; Block ML; Hong JS
J Immunol; 2008 Nov; 181(10):7194-204. PubMed ID: 18981141
[TBL] [Abstract][Full Text] [Related]
4. Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation.
Liu Y; Qin L; Li G; Zhang W; An L; Liu B; Hong JS
J Pharmacol Exp Ther; 2003 Apr; 305(1):212-8. PubMed ID: 12649371
[TBL] [Abstract][Full Text] [Related]
5. Andrographolide reduces inflammation-mediated dopaminergic neurodegeneration in mesencephalic neuron-glia cultures by inhibiting microglial activation.
Wang T; Liu B; Zhang W; Wilson B; Hong JS
J Pharmacol Exp Ther; 2004 Mar; 308(3):975-83. PubMed ID: 14718612
[TBL] [Abstract][Full Text] [Related]
6. Parkinson disease IgG and C5a-induced synergistic dopaminergic neurotoxicity: role of microglia.
Wang XJ; Yan ZQ; Lu GQ; Stuart S; Chen SD
Neurochem Int; 2007 Jan; 50(1):39-50. PubMed ID: 16971022
[TBL] [Abstract][Full Text] [Related]
7. Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage through inhibition of microglia activation and proinflammatory factors generation.
Chen HQ; Jin ZY; Li GH
Neurosci Lett; 2007 May; 417(2):112-7. PubMed ID: 17399896
[TBL] [Abstract][Full Text] [Related]
8. Prothrombin kringle-2 induces death of mesencephalic dopaminergic neurons in vivo and in vitro via microglial activation.
Kim SR; Chung ES; Bok E; Baik HH; Chung YC; Won SY; Joe E; Kim TH; Kim SS; Jin MY; Choi SH; Jin BK
J Neurosci Res; 2010 May; 88(7):1537-48. PubMed ID: 20025058
[TBL] [Abstract][Full Text] [Related]
9. Thrombin-activated microglia contribute to death of dopaminergic neurons in rat mesencephalic cultures: dual roles of mitogen-activated protein kinase signaling pathways.
Lee DY; Oh YJ; Jin BK
Glia; 2005 Aug; 51(2):98-110. PubMed ID: 15789435
[TBL] [Abstract][Full Text] [Related]
10. Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease.
Gao HM; Liu B; Zhang W; Hong JS
FASEB J; 2003 Oct; 17(13):1954-6. PubMed ID: 12897068
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by naloxone stereoisomers of beta-amyloid peptide (1-42)-induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons.
Liu Y; Qin L; Wilson BC; An L; Hong JS; Liu B
J Pharmacol Exp Ther; 2002 Sep; 302(3):1212-9. PubMed ID: 12183682
[TBL] [Abstract][Full Text] [Related]
12. 3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity.
Zhang W; Qin L; Wang T; Wei SJ; Gao HM; Liu J; Wilson B; Liu B; Zhang W; Kim HC; Hong JS
FASEB J; 2005 Mar; 19(3):395-7. PubMed ID: 15596482
[TBL] [Abstract][Full Text] [Related]
13. A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation.
Kim YS; Choi DH; Block ML; Lorenzl S; Yang L; Kim YJ; Sugama S; Cho BP; Hwang O; Browne SE; Kim SY; Hong JS; Beal MF; Joh TH
FASEB J; 2007 Jan; 21(1):179-87. PubMed ID: 17116747
[TBL] [Abstract][Full Text] [Related]
14. Interactive role of the toll-like receptor 4 and reactive oxygen species in LPS-induced microglia activation.
Qin L; Li G; Qian X; Liu Y; Wu X; Liu B; Hong JS; Block ML
Glia; 2005 Oct; 52(1):78-84. PubMed ID: 15920727
[TBL] [Abstract][Full Text] [Related]
15. Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon.
Sawada H; Shimohama S; Tamura Y; Kawamura T; Akaike A; Kimura J
J Neurosci Res; 1996 Jan; 43(1):55-62. PubMed ID: 8838574
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic neurotoxicity by 6-OHDA and MPP+: differential requirement for neuronal cyclooxygenase activity.
Carrasco E; Casper D; Werner P
J Neurosci Res; 2005 Jul; 81(1):121-31. PubMed ID: 15931668
[TBL] [Abstract][Full Text] [Related]
17. Microglial activation induced by neurodegeneration: a proteomic analysis.
Zhou Y; Wang Y; Kovacs M; Jin J; Zhang J
Mol Cell Proteomics; 2005 Oct; 4(10):1471-9. PubMed ID: 15975914
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of microglial contribution to mouse strain-dependent dopaminergic neurotoxicity.
McLaughlin P; Zhou Y; Ma T; Liu J; Zhang W; Hong JS; Kovacs M; Zhang J
Glia; 2006 Apr; 53(6):567-82. PubMed ID: 16419087
[TBL] [Abstract][Full Text] [Related]
19. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation.
Liu B; Du L; Hong JS
J Pharmacol Exp Ther; 2000 May; 293(2):607-17. PubMed ID: 10773035
[TBL] [Abstract][Full Text] [Related]
20. New evidences for fractalkine/CX3CL1 involved in substantia nigral microglial activation and behavioral changes in a rat model of Parkinson's disease.
Shan S; Hong-Min T; Yi F; Jun-Peng G; Yue F; Yan-Hong T; Yun-Ke Y; Wen-Wei L; Xiang-Yu W; Jun M; Guo-Hua W; Ya-Ling H; Hua-Wei L; Ding-Fang C
Neurobiol Aging; 2011 Mar; 32(3):443-58. PubMed ID: 19368990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
